ROSSARI

Rossari Biotech, a small-cap player in the chemicals industry, has recently experienced a shift in its technical trend from mildly bearish to bearish. The company's current stock price stands at 619.45, slightly up from the previous close of 617.50. Over the past year, Rossari Biotech has seen a 52-week high of 966.00 and a low of 582.40, indicating significant volatility. The technical summary reveals a bearish outlook in several key indicators. The MACD shows a bearish trend on a weekly basis and a mildly bearish trend monthly. The Relative Strength Index (RSI) indicates a bullish signal weekly, but no signal monthly. Bollinger Bands reflect a bearish trend for both weekly and monthly periods. Daily moving averages also suggest a bearish stance. The KST shows a bearish trend weekly, while it remains bullish monthly. Dow Theory indicates a mildly bearish trend for both weekly and monthly assessments, and the On-Balance Volume (OBV) shows no trend weekly but is mildly bullish monthly. In terms of performance, Rossari Biotech's stock has underperformed compared to the Sensex across various time frames. Over the past week, the stock returned -3.44%, while the Sensex returned -2.81%. In the one-month period, Rossari Biotech's return was -11.38% compared to the Sensex's -3.56%. Year-to-date, the company has seen a decline of 21.36%, while the Sensex has only dropped 6.32%. Over the past year, Rossari Biotech's stock has decreased by 17.1%, contrasting with a modest gain of 1.24% for the Sensex. The three-year return for Rossari Biotech stands at -36.96%, while the Sensex has appreciated by 30.14%.